THE USE OF PERGOLIDE, A POTENT DOPAMINE AGONIST, IN PARKINSONS-DISEASE

被引：12

作者：

LIEBERMAN, AN ^{[1
]}

GOLDSTEIN, M ^{[1
]}

NEOPHYTIDES, A ^{[1
]}

LEIBOWITZ, M ^{[1
]}

GOPINATHAN, G ^{[1
]}

WALKER, R ^{[1
]}

PACT, V ^{[1
]}

机构：

[1] NYU, SCH MED, NEW YORK, NY 10003 USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1982年 / 32卷 / 01期

关键词：

D O I：

10.1038/clpt.1982.128

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：70 / 75

页数：6

共 25 条

[1]

BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5

[2]

CALNE DB, 1978, LANCET, V1, P735

[3] L-DOPA TREATMENT IN PARKINSONS DISEASE - EFFECT ON DOPAMINE AND RELATED SUBSTANCES IN DISCRETE BRAIN REGIONS [J].

DAVIDSON, L ;

LLOYD, K ;

DANKOVA, J ;

HORNYKIEWICZ, O .

EXPERIENTIA, 1971, 27 (09) :1048-+

[4] ON-OFF PHENOMENON WITH LEVODOPA THERAPY IN PARKINSONISM - CLINICAL AND PHARMACOLOGIC CORRELATIONS AND EFFECT OF INTRAMUSCULAR PYRIDOXINE [J].

FAHN, S .

NEUROLOGY, 1974, 24 (05) :431-441

[5] INTERACTION OF PERGOLIDE WITH CENTRAL DOPAMINERGIC RECEPTORS [J].

GOLDSTEIN, M ;

LIEBERMAN, A ;

LEW, JY ;

ASANO, T ;

ROSENFELD, MR ;

MAKMAN, MH .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (06) :3725-3728

[6]

Goldstein M, 1980, Adv Biochem Psychopharmacol, V23, P75

[7]

GOLDSTEIN M, 1979, DOPAMINERGIC ERGOT D, P253

[8]

GOLDSTEIN M, 1976, ADV PARKINSONISM, P236

[9] PARKINSONISM - ONSET PROGRESSION AND MORTALITY [J].

HOEHN, MM ;

YAHR, MD .

NEUROLOGY, 1967, 17 (05) :427-&

[10] MECHANISMS OF ACTION OF L-DOPA IN PARKINSONS-DISEASE [J].

HORNYKIEWICZ, O .

LIFE SCIENCES, 1974, 15 (07) :1249-1259

← 1 2 3 →